Skip to main content
In stock|Immunotherapy (Monoclonal Antibody)

Veltuzumab

Oncology TypeHematologic (Lymphoma/CLL)
Drug Class / MechanismAnti-CD20 mAb
No Image
Description

Veltuzumab is classified as an Anti-CD20 mAb, sourced for use within our Immunotherapy (Monoclonal Antibody) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryImmunotherapy (Monoclonal Antibody)
Oncology TypeHematologic (Lymphoma/CLL)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3